Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.33 |
| ▸ | PPARG | P37231 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 6/20 | 0.33 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.32 |
| ▸ | GCLC | P48506 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LAP3 | P28838 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7716769 | 0.83 | CYP2D6 (0.42) | HSD17B10CYP2D6CYP2C9CYP2C19EPHX2 | |
| SCHEMBL7718882 | 0.82 | CYP2D6 (0.39) | HSD17B10CYP2D6CYP2C9CYP2C19EPHX2 | |
| SCHEMBL27334920 | 0.79 | HSD17B10 (0.51) | HSD17B10CYP2D6CYP2C9CYP2C19FOLH1 | |
| Phosphoric Acid SCHEMBL27426833 | 0.77 | ALDH1A1 (0.42) | HSD17B10CYP2D6CYP2C9CYP2C19EPHX2 | |
| SCHEMBL13541257 | 0.75 | CPA1 (0.44) | HSD17B10CYP2C19MEN1NPC1KMT2A | |
| SCHEMBL13555039 | 0.75 | CPA1 (0.44) | HSD17B10CYP2C19MEN1NPC1KMT2A | |
| SCHEMBL17617124 | 0.75 | CPA1 (0.44) | HSD17B10CYP2C19MEN1NPC1KMT2A | |
| SCHEMBL7718908 | 0.75 | CYP2D6 (0.40) | HSD17B10CYP2D6CYP2C9CYP2C19EPHX2 | |
| SCHEMBL7718813 | 0.73 | CYP2D6 (0.44) | CYP2D6CYP2C9CYP2C19EPHX2PPARG | |
| SCHEMBL284647 | 0.72 | ALDH1A1 (0.50) | HSD17B10EPHX2PPARGMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376512-B1 | FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-23 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |